COMMUNIQUÉS West-GlobeNewswire

Nabriva Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
10/05/2019
DUBLIN, Ireland, May 10, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections, today [...]
Trevena Reports First Quarter 2019 Results
10/05/2019
— Company announces receipt of FDA feedback on healthy volunteer study protocol and analysis plan for oliceridine — – Study on track to initiate by end of June – Company to host conference call Monday, May 13, 2019 at 8 [...]
Amicus Therapeutics to Present at the Bank of America Merrill Lynch 2019 Health Care Conference
10/05/2019
CRANBURY, N.J., May 10, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that John F. Crowley, Chairman and Chief Executive Officer, will participate in a fireside chat at the Bank of America [...]
ContraFect Reports First Quarter 2019 Financial Results and Provides Business Update
10/05/2019
YONKERS, N.Y., May 10, 2019 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents, comprised of lysins and [...]
Recro Pharma Reports First Quarter 2019 Financial Results
10/05/2019
Company to Host Conference Call Today at 8:00 AM ET MALVERN, Philadelphia, May 10, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a pharma company with a high-performing, revenue generating contract [...]
TG Therapeutics Provides Business Update and Reports First Quarter 2019 Financial Results
10/05/2019
Conference Call to be held today, Friday, May 10, 2019 at 8:00 AM ET NEW YORK, May 10, 2019 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its financial results for the first quarter ended [...]
FDA Approves Prior Approval Supplement for BIVIGAM®
10/05/2019
ADMA Announces it will Commence Commercial Sales of BIVIGAM® RAMSEY, N.J. and BOCA RATON, Fla., May 10, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated [...]
PLx Pharma Inc. Reports First Quarter 2019 Results
10/05/2019
Company submits briefing package to U.S. Food and Drug Administration HOUSTON, May 10, 2019 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company [...]
Stemline Therapeutics Reports First Quarter 2019 Financial Results
10/05/2019
Net revenue for ELZONRIS was $5.05 million for the first quarter Conference call and live webcast scheduled for today at 8:00 AM ET NEW YORK, May 10, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), [...]
Zomedica Announces Private Placement of Preferred Shares
10/05/2019
ANN ARBOR, Mich., May 10, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company, today announced that it [...]
Amphastar Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference 2019
10/05/2019
RANCHO CUCAMONGA, Calif., May 10, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Jason Shandell, President and Bill Peters, CFO, will be presenting at the Bank of America [...]
Adynxx Announces Payment Date of Special Cash Dividend Previously Announced by Alliqua BioMedical
10/05/2019
Adynxx announces May 29, 2019 as payment date of previously announced special cash dividend of $1.05 per share to former Alliqua shareholders Adynxx confirms intent to consummate the previously announced distribution of [...]
ASLAN Pharmaceuticals’ Varlitinib Selected by Leading Korean Gastric Cancer Group for Study in Second-Line Gastric Cancer
10/05/2019
- K-MASTER, Korea’s leading precision medicine research group, to conduct phase 1b/2 umbrella study testing varlitinib as a second-line treatment in HER1/HER2 co-expressing advanced or metastatic gastric cancer patients [...]
Virbac : Declaration of the number of shares and voting rights April 2019
10/05/2019
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]
Virbac : Déclaration d'actions et droits de vote Avril 2019
10/05/2019
DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions composant le capital (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) [...]
Ambu A/S: Ambu appoints new CEO
10/05/2019
Ambu’s board of directors has appointed Juan-José Gonzalez as the new CEO, effective May 15, 2019, to replace Lars Marcher who resigns from his position. Jens Bager, Chairman of the Ambu Board of Directors, comments, “ [...]
GENFIT: Ordinary Shareholder’s Meeting of June 13, 2019 – Availability of Preparatory Documents
10/05/2019
GENFIT: Ordinary Shareholder’s Meeting of June 13, 2019 – Availability of Preparatory Documents Lille (France), Cambridge (Massachusetts, United States), May 10, 2019 – GENFIT (Nasdaq and Euronext: GNFT) , a late-stage [...]
GENFIT : Assemblée générale ordinaire du 13 juin 2019 – modalités de mise à disposition des documents préparatoires
10/05/2019
GENFIT : Assemblée générale ordinaire du 13 juin 2019 – modalités de mise à disposition des documents préparatoires Lille (France), Cambridge (Massachusetts, États-Unis), le 10 mai 2019 – GENFIT (Nasdaq et Euronext: [...]
Bone Therapeutics SA: The preliminary documents for the Annual Ordinary General Shareholder Meeting on 12 June 2019 have been made available
10/05/2019
Regulated information Gosselies, Belgium, 10 May 2019, 7 am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone [...]

Pages